Share
Research from the University of Virginia School of Medicine suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.
Share
A cancer stem cell research company founded by Fralin Biomedical Research Institute at VTC scientists is nearing a million dollars in total funding toward development of a new therapeutic to fight drug-resistant cancers.
Share
Mental time travel — transporting someone from the present through imagining a personal, positive future event — has been proven to help reduce alcohol, tobacco, and drug use.
Share
If you have a business idea and you want to maximize your chances of turning that idea into a successful reality, it’s important to do your research proactively.
Share
Through collaboration that incorporates the use of computational modeling, data, and virology, a group of Virginia Tech researchers tackles the latest questions surrounding COVID-19.
Share
Tamp down one cyberattack, and another pops up — threatening both livelihoods and lives across industries and sectors.
Share
Leading global aerospace and defense company Northrop Grumman has become a key strategic partner of the Virginia Tech Innovation Campus by making a $12.5 million commitment to support research and teaching in quantum information science and engineering.
Share
The FDA has approved an incisionless form of brain surgery to treat advanced Parkinson’s after testing at the University of Virginia School of Medicine and other sites.
Share
Cancer immunotherapy, one of the most important and promising therapies for cancer treatments, is being used by oncologists to treat patients suffering from many different cancers including breast, cervical, colon, stomach, and skin.
Share
Virginia Tech College of Science Interim Dean Ron Fricker updated the Virginia Tech Board of Visitors on Sunday, Nov. 7.
Our content is free to read, but we do have bills to pay. Pitch in and help us keep the community informed.